About 2EyesVision
2EyesVision is a Healthcare company based in Madrid (Spain) founded in 2015 by Susana Marcos and Carlos Dorronsoro Diaz. Portable technologies for multifocal eye corrections before surgeries are developed. 2EyesVision has raised $100 thousand across 6 funding rounds from investors including EIT Health, European Union and Luminate. Its chief executive, as recorded, is Carlos Dorronsoro Diaz. 2EyesVision offers products and services including SimVis Gekko. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Imaging.
Company details
Founded in 2015 in Madrid, Spain, the company operates in the medical technology sector, specializing in ophthalmology. Portable devices such as SimVis, an intraocular lens simulator, are provided for diagnostic purposes in cataract and refractive surgeries or contact lens fittings. Multifocal corrections are prescribed and binocular presbyopic options are compared using programmable features, a wide field-of-view, lightweight head-mounted design, and remote operation capabilities.
- Total Equity Funding$100K (USD)
in 6 rounds
- Latest Funding Round$100K (USD), Series A
Mar 2021
- InvestorsEIT Health
& 3 more
Products & Services of 2EyesVision
2EyesVision offers a comprehensive portfolio of products and services, including SimVis Gekko.
Simulates presbyopia corrections for personalized patient vision assessments.
Apps and channels of 2EyesVision
its YouTube channel 2EyesVision has 65 subscribers and 30 videos.
Videos from 2EyesVision
The most watched videos on 2EyesVision's YouTube channel, 2EyesVision (65 subscribers). Click a video to play it here.
More on 2EyesVision.
Funding Insights of 2EyesVision
2EyesVision has successfully raised a total of $100K across 6 strategic funding rounds. The most recent funding activity was a Series A round of $100 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $100,000
- Total Rounds 6
- Last Round Series A — $100,000
- Investors Count 4
All 6 funding rounds of 2EyesVision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $100,000 | Series A | – | – | |
| Jan 2018 | $211,572 | Grant | – | – | |
| Dec 2017 | Series A | – | – | ||
| Sep 2017 | $91,923 | Grant | – | – | |
| Jul 2017 | $57,330 | Grant | – | – | |
| Jun 2017 | Seed | – | Bullnet Capital | – |
4 investors in total: 4 institutional.
Investors in 2EyesVision
2EyesVision has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include EIT Health, European Union and Luminate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
AR/VR and biophotonics accelerator program is operated in Rochester. | luminate.org | Rochester, United States | ||
High-tech Spanish startups are funded by Bullnet Capital. | bullnetcapital.com | Pozuelo de Alarcón, Spain | ||
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for 2EyesVision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of 2EyesVision
2 people are tracked at 2EyesVision (2 in leadership).
| Name | Role | Group |
|---|---|---|
Susana Marcos | Co-Founder | Leadership |
Carlos Dorronsoro Diaz | Co-Founder & CEO | Leadership |
Complete people profiles for 2EyesVision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of 2EyesVision
3 dated milestones of 2EyesVision across 6 years, from founding to its latest funding, stage changes and deals.
- Founded 2EyesVision is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $100K.
Web traffic of 2EyesVision
Websites that share an audience with 2EyesVision (2eyesvision.com).
Websites whose visitors overlap most with 2EyesVision. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| secpho.org | 100% | 2.5K | #7,021,229 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about 2EyesVision
2EyesVision was founded in 2015 and raised its 1st funding round 2 years after it was founded.
2EyesVision is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Carlos Dorronsoro Diaz is the CEO of 2EyesVision, as recorded in our data. They have also founded this company.
2EyesVision is a funded company, having raised a total of $100K across 6 funding rounds to date.
Founded in 2015 in Madrid, Spain, the company operates in the medical technology sector, specializing in ophthalmology. Portable devices such as SimVis, an intraocular lens simulator, are provided for diagnostic purposes in cataract and refractive surgeries or contact lens fittings. Multifocal corrections are prescribed and binocular presbyopic options are compared using programmable features, a wide field-of-view, lightweight head-mounted design, and remote operation capabilities.
2EyesVision offers SimVis Gekko.
2EyesVision has 4 investors. Key investors include EIT Health, European Union, Luminate, and Bullnet Capital.